New funds back Axelar's IGF-1 receptor inhibitor in NSCLC
13 May 2011
Sukaina Virji
Please Login to read the full article.
13 May 2011
Sukaina Virji
sukaina.virji@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- China's first homegrown EGFR inhibitor to be provided free to some patients
- Without direct Iressa comparison, NICE wants more on Roche's Tarceva for NSCLC
- Serono-Ono co-co- for go/no-go on so-so onco Stimuvax
- Kyowa Kirin takes tivantinib into Asian Phase III trial for lung cancer
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
